Investigation of the effectiveness of fluoroscopic erector spine plane block

Investigation of the effectiveness of fluoroscopic erector spine plane block - Investigation of the effectiveness of fluoroscopic erector spine plane block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049828

Enrollment

Registered

2022-12-26

Start date

2023-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior lumbar fusion of one or two vertebrae

Interventions

fluoroscopic erector spine plane block group ultrasound erector spine plane block group control group (no block)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients body weight more than 45kg and less than 100kg American Society of Anesthesiologists grade I, II, or III Patients who will undergo 1- or 2-vertebral open lumbar posterior fusion

Exclusion criteria

Exclusion criteria: Previous spinal surgery Renal dysfunction (eGFR<60mL/min/1.73m2) Hepatic dysfunction (AST>30, ALT>30) drug (loxoprofen Na, acetaminophen, ropivacaine, fentanyl) allergy Complicated pyogenic spondylitis Complicated spinal fracture Complicated bladder and rectal disorders Complicated preoperative paresthesia of the lower extremities with inability to walk Complications of malignant tumor

Design outcomes

Primary

Measure	Time frame
Postoperative low back pain VAS (0hr, 1hr, 2hr, 6hr, 12hr, 24hr, first walk after drain removal)	—

Secondary

Measure	Time frame
Age Sex Body weight Duration of blocking procedure iv-PCA consumption in the first 24 hours after surgery Number of times rescue drug (1000 mg IV acetaminophen) was used Time from postoperative to first rescue drug delivery Satisfaction (on a scale of 1-5) Number of cases of high-level mistakes in the ultrasound group Dose area product Duration of radiation exposure Complications of ESPB (paraplegia, local anesthesia, needle site infection) Postoperative hematoma Dural injury Postoperative infection	—

Measure

Time frame

Age Sex Body weight Duration of blocking procedure iv-PCA consumption in the first 24 hours after surgery Number of times rescue drug (1000 mg IV acetaminophen) was used Time from postoperative to first rescue drug delivery Satisfaction (on a scale of 1-5) Number of cases of high-level mistakes in the ultrasound group Dose area product Duration of radiation exposure Complications of ESPB (paraplegia, local anesthesia, needle site infection) Postoperative hematoma Dural injury Postoperative infection

—

Countries

Japan

Contacts

Public ContactShusuke Hagihara

Faculty of Medicine, Fukuoka University Department of Orthopedics Surgery

s.hagihara1410@gmail.com092-801-1011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026